Japan Medical Dynamic Marketing (FRA:JMD) Research & Development: €4.9 Mil (TTM As of Mar. 2026)


FRA:JMD Japan Medical Dynamic Marketing Inc FRA:JMD
77 GF Score
Price €4.98
GF Value €3.39
! 12 Warning Signs
View Full Analysis

What is Japan Medical Dynamic Marketing Research & Development?

Japan Medical Dynamic Marketing FRA:JMD +2.89% 77 Research & Development is €4.9 Mil as of Mar. 2026. GuruFocus rates FRA:JMD with a GF Score™ of 77/100 and a GF Value™ of €3.39. The stock has 12 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Japan Medical Dynamic Marketing's Research & Development for the three months ended in Mar. 2026 was €1.1 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €4.9 Mil.

Japan Medical Dynamic Marketing  (FRA:JMD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Japan Medical Dynamic Marketing Research & Development Related Terms

Japan Medical Dynamic Marketing Research & Development Historical Data

* Premium members only.

The historical data trend for Japan Medical Dynamic Marketing's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Japan Medical Dynamic Marketing Research & Development Chart

Japan Medical Dynamic Marketing Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.72 4.63 5.37 5.96 4.72

Japan Medical Dynamic Marketing Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.45 1.31 1.46 1.07 1.08
FRA:JMD
77GF Score
Japan Medical Dynamic Marketing Inc FRA:JMD
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Japan Medical Dynamic Marketing Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €4.9 Mil mean?
Japan Medical Dynamic Marketing (FRA:JMD) has a Research & Development of €4.9 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Japan Medical Dynamic Marketing and its competitors.
Is Japan Medical Dynamic Marketing's Research & Development too high?
Japan Medical Dynamic Marketing's current Research & Development is €4.9 Mil. Overall, Japan Medical Dynamic Marketing has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Japan Medical Dynamic Marketing's Research & Development compare to ABT and SYK?
Japan Medical Dynamic Marketing's Research & Development of €4.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Japan Medical Dynamic Marketing and its competitors. Japan Medical Dynamic Marketing's current Research & Development is €4.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Medical Dynamic Marketing stock overvalued right now?
Japan Medical Dynamic Marketing (FRA:JMD) has a current Research & Development of €4.9 Mil. The stock's GF Value™ is €3.39, compared to a current price of €4.98 — trading 46.9% above its estimated fair value. The current Research & Development is €4.9 Mil. Japan Medical Dynamic Marketing's overall GF Score™ is 77/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Japan Medical Dynamic Marketing (FRA:JMD), the current Research & Development is €4.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Japan Medical Dynamic Marketing (FRA:JMD) Overvalued in 2026?

Based on GuruFocus' analysis, Japan Medical Dynamic Marketing stock appears to be overvalued. The current stock price of €4.98 is trading 46.9% above its estimated GF Value™ of €3.39.

Key valuation signals for FRA:JMD:

  • Research & Development: €4.9 Mil
  • GF Value™: €3.39 vs. price of €4.98 (46.9% above fair value)
  • GF Score™: 77/100 with 12 warning signs

No single metric tells the full story. See the FRA:JMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Japan Medical Dynamic Marketing Business Description

Other Exchanges JMDMF:USA7600:Japan
Address 12-2, Ichigayadaimachi, Shinjuku-ku, Tokyo, JPN, 162-0066
Japan Medical Dynamic Marketing Inc is a Japan-based medical equipment manufacturer. The company is engaged in the development and sale of advanced medical devices. Products offered by the company include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. It caters its products to medical professionals and major hospitals throughout Japan. The company is also engaged in the import and sale of medical devices.
77GF Score

Get the complete analysis for FRA:JMD

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.98
Price
€3.39
GF Value